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Abstract
The ever-changing economic criteria system of the
last 25 years proved to be a challenge for the
Hungarian husbandry. The Regime Change, entry into
the European Union, and the current trend of market
globalisation cause changes and uncertainty. This
results in significant tasks for experts working in the
farm management. The vet profession prefers
prevention instead of the classic curative activities.
Knowing the technological solutions of farms is
required for all these. Also, production indices and
costs have to be followed in order to realise animal
health management that produces an income. The
dairy farm in the current analysis can be said to be
sufficient in terms of animal health, taking the
domestic level of herd health into consideration - and
excluding calf healthcare. Furthermore, the costs of
livestock drugs generate a return quickly. Based on
the data of the analysis, the total specific costs of
drugs are an average 23,582 HUF for each cow
annually. This generated a return for an excess milk
of 237.8 per cow annually. Naturally, the
continuously growing market price of milk also
influenced the return, which is a somewhat confusing
economic circumstance, in regards to the financial
efficiency of drug usage.
Keywords
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1. Introduction
The ultimate goal of those who own dairy farms is to
sustain the long-term profitability of their property.
Therefore, they have to adapt to market demands. The
Regime Change, entry into the European Union, and
the current trend of market globalisation cause
changes and uncertainty. This results in significant
tasks for experts working in the farm management.
The vet profession prefers prevention instead of the
classic curative activities. Knowing the technological
solutions of farms is required for all these. Also,
production indices and costs have to be followed in
order to realise animal health management that
produces an income. The consumer and market
demands are always changing, and adapting to them
requires quickly executed technological changes. The
fastest to react are the ones to stay standing on the
market. This can only work if experts can measure
expected effects during their decisions as accurately
as possible, and to the greatest possible detail.
Managing dairy farms demands more and more
economic-related knowledge from vets, and for them
to measure the consequences of their decisions on
animal health. The current study aims to
comparatively analyse a commercial dairy farm's
production indices, animal health state and drug usage. 
2. The general economic environment of bovine
husbandry
2.1. Most notable changes in the dairy cow sector
In 2000, the Hungarian dairy farms gave 11-12% of the
total agricultural production [1], but grew until 20% by
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2012 [2]. In other words, their economic role is a very
important one in agriculture. The bovine husbandry of
nations, which have a modern agriculture, underwent
significant changes. In spite of the constant decrease of
the livestock numbers, the milk yield per cow
constantly increased. This was caused by the
development of genetics, and the modernisation of farm
technological solutions. Though the number of dairy
farms decreased, their average number of livestock
increased, which means the herd size became large. The
cost-intensity of modern technologies is very high,
which significantly increased the amount of capital the
sector needs. At the same time, the work of vets
changed fundamentally as well: preventing herd health
problems became the most important, by which the
production of the farm can be increased [3].
2.2. Main factors determining the profit of bovine
husbandry
Profit is determined by the costs and returns of
production, and most notably the milk price in our
case. The quantity and quality of produced milk is
influenced by many factors, some of which are: the
genetics, the housing technology, the herd size, the
level of feeding, the rate of culling, the state of
reproduction, and the animal health management.
These all determine production costs which might be
decreased by high-tech information technology, good
farm management including efficient planning,
determined and accurate employees. However, costs
related to environmental protection (f. e. manure
handling) and animal protection are unavoidable, due
to the European Union regulations. Apart from the
milk sales, calves, breeding animals, culled cows, and
manure can also generate some income. If we subtract
the fixed and variable production costs from the
income, we get the profits [3].
2.3. Effects of diseases on the production of the
dairy farm
Ferenc Kovács said the following in 1975: "an animal
is healthy, if it can produce according to its genetic
capacity, within the confines of being economically
sound". Multifactoral diseases are caused by many
correlated factors, and the general symptom of the
disease is made up of the pathogens, however, risk
factors do have a significant role to play, e.g. housing
and feeding disorders. The most notable economic
losses of dairy farming are caused by mastitis,
reproductive disorders, lameness, and respiratory
diseases (BRDC) [3]. Multifactoral diseases can be
efficiently avoided by animal health programmes
based on environmental checks [4].
2.4. Production indices and drug costs of dairy
farms
Animal health technology significantly influences the
production indices and drug costs of dairy farms. It's
a fact that prevention is always cheaper than the
curation of already existing diseases [3, 5]. Ózsvári
et al. [6] compared the production indices (the
quantity of marketed milk, progeny and mortality and
culling rate) to animal health drug costs. They
categorized the drug costs based on product groups
and indication. Most of the costs were made up of
drugs used to treat mastitis (45% and 50%,
respectively) for two dairies, and to treat fertility
problems (40%) for a third one. The costs of
antibiotics were the most notable for all three farms
(46.8% on average). If we take a look at the costs of
antibiotics by indication, we can see that for all three
herds, the antibiotics used for mastitis were the most
costly (72.7% on average). The average costs of
vaccines amounted to 9.5%, whereas those of
disinfectants to 8.9%, hormones to 12.3%, and
vitamins - nutrient supplements to 11.6%. Ózsvári et
al. [6] calculated that the annual drug costs for a cow
amount to an average of 10.560 HUF, the specific
drug costs for mastitis to an average of 0.6l
HUF/1/year, and the specific drug costs for
reproduction disorders to an average of 2,425
HUF/calf/year for the three farms. The costs of drugs
used for udder treatment generate a return in case of
an annual surplus of 70 litres milk produced for each
cow. The drug costs spent on reproduction disorders
generate a return in case of an annual 0.043 extra calf
for each cow.
Varga and Ózsvári [7] compared the production
indices of a dairy farm with the vet drug costs for the
2000-2002 period. Out of the production indices, the
marketed milk increased with the years - in spite of
no change in the number of livestock. 44.9% of all
drug costs were spent for antibiotics, 7.3% went to
disinfectants, 13.1% to vitamins and nutrient
supplements, 11.5 to hormones, and 10.9% to
vaccines. The specific drug costs increased to almost
300% within three years: in 2000, they amounted to
17,400 HUF, which increased to 31,500 HUF by
2002. This can be explained by the substantial
increase of antibiotics, vitamin and vaccine costs. The
share of vitamins, nutrient supplements and vaccines
have of all costs also increased substantially. The total
drug costs for 1 litre milk increased from 3 HUF to
4.4 HUF. On this farm, the costs invested into mastitis
treatment drugs generated a return in case an average
349.7 litres extra milk for each cow. The drug costs
for 1 litre of milk increased, meaning the economic
efficiency of drug usage decreased.
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Szerémi [8] evaluated a dairy farm housing 1000
cows, based on comparing their production indices
and drug costs. The amount of cows increased slightly
between 2003 and 2005, which also caused milk
production to increase. The drug costs for one cow
was 17,716 HUF, amounting to 2.14 HUF for a litre
of milk. Categorized by indication, the preventive
drugs (vaccines, disinfectants) were the most
significant (with 36.8%) on the farm. This was
followed by drugs used to treat reproductive disorders
(25.9%) and those used to treat mastitis with 23.3%.
41% of all costs were used for antibiotics. The
amount of disinfectants was 24%, which is over three
times as much as the previous data. Hormones took
up 10% of the costs, whereas vaccines were
accounted for 13%. Szerémi [8] detailed the
preventive drugs and antibiotics categories according
to indication and active substances. 45.9% of
preventative drugs in this analysis were udder
disinfectants, and 54% were drugs used for mastitis.
According to the average data of analyses conducted
at Hungarian dairy farms, total drug costs consist of
45.2% antibiotics, 12.8% disinfectants, 11.7%
hormones, and 10.6% vaccines. 68.4% of antibiotics
on average are used for udder treatment [3, 6, 7, 8, 9].
Based on the literature, we can say that the production
indicators and drug costs are very varied. Therefore,
we think that there's a very good opportunity for
increasing economic efficiency via well-designed
animal health programs.
3. Materials and methods
During the research field work, we analysed a
southern Great Plains dairy farm, where an average
of 732 cows were kept during the analysis timeframe.
70% of the animals were of pure Holstein Friesian
breed, and the remaining were crossbreeds of
Norwegian Reds. The dairy farm had six production
stables, each with 120 cattle capacity and deep litter.
Four of these are modern, large internal height ones
outfitted with collaring machines. Before calving,
cows are kept in a dry stable for 7-8 weeks, along
with heifers in calves. Two weeks before the expected
time of calving, the animals are moved to the
preparation area, and into the calving area right before
calving, which is in the same building. The stable is
loose-housed with deep litter, well-lit, has a collaring
machine, and contains crucibles for calving and
operations. There are 5-10 cows waiting for calving
in the calving area on average. 3 days after calving,
if the cow is capable of production according to the
checkups, it's released from the calving area, and led
into production stable No. 1. Her state of health is
monitored every day for 30 days after this. Calves are
separated from their mothers 1 hour after birth, after
they consumed at least 1.5 litres of colostrum. After
this, the calves are raised in special cubicles until
they're 10-14 days old, from where males are sold for
further keeping. Heifers are moved to the new large
internal height calf raiser constructed in 2013, which
houses 12 × 20 calves total. The four compartments
in the centre are outfitted with Westfalia milk feeders
offering milk substitute from a pacifier for each
group. 2-3 weeks after a selection process, they're
moved to the calf group raising area with deep litter.
When they reach 6-8 months of age, they're herded
to the neighbouring stables for youngsters, from
where they're conceived at 15 month age, in case their
body size is adequate. After positive pregnancy
check, they're sent to the neighbouring dry cow
stables with the other cows. 
The milking is done using an old Westfalia 2×9
fishbone milking machine with a low milk canal, until
the new Gea carousel system milking house is
installed by mid-2015. The cows, the young and the
separated calves are fed with monodiet, the group
feeding is done from feeding tables. The production
group is fed two times a day, whereas the others are
fed once a day. Refreshing and retracting the Total
Mixed Ration (TMR) is done 4-5 times a day. The
TMR is distributed using a 12 m3 Eurocomp feeding
car pulled by a tractor, linked to a computer and a
scale. The feeding materials used on the farm are:
corn silage, alfalfa silage, grass bale silage, green
wheat, triticale bale silage, alfalfa hay, grass hay,
sugar beet slices and sweet pickled corn by-products. 
The owners of the farm find feeding very important
with a high fibre content, constant compound and
homogeneous TMR based on exceptional roughage.
They also set the bedding exceptionally well. They
don't aim for an outstanding milk production,
however, their cows' life expectancy is high, while
the mortality and culling are kept low. The herd is
officially free of tuberculosis, brucellosis and
leucosis, and leptospirosis does not take place. They
sold many in-calf heifers to the post-Soviet states, and
purchased young heifers and calves with exceptional
genetics from the Netherlands to replace them.
In the first part of our analysis, we collected the
production indices of the dairy farm for the 2012-
2014 period. We calculated the average drug costs of
the herd by multiplying their amounts with their net
prices of the three years. This process was done in
accordance with other references [3, 6, 7, 8, 9], and
sorted them by year, product groups and indication.
We analysed how the costs of antibiotics were in
detail, based on indication and active substance. To
facilitate comparisons, we calculated the annual drug
costs for one cow and one litre of milk. We evaluated
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the correlation between drug usage and production
indices. We compared the milk production and
reproductive parameters to the udder health and
fertility treatment drug costs. We also compared the
mortality rate with the total drug cost per cow, and
the calf drug costs per calf to the calves' mortality
rate. Afterwards, using all the collected data, we
calculated the recovery of drug costs in the herd.
4. Results and discussion
4.1. Comparative analysis of production indices and
drug costs on the dairy farm
We calculated the annual udder health drug cost per
cow and the annual fertility treatment drug cost per
cow, and compared them to the related production
parameters. This way, we were able to analyse the
efficiency of drug usage. When evaluating the
efficiency of calf health management, we compared
the annual drug costs per calf to the calves' mortality
rate. In order to evaluate the total drug usage of the
dairy farm, we compared the cows' mortality rate to
the annual drug costs per cow.
4.1.1. Specific drug costs and production indices
The specific udder health drug costs are the quotient
of the annual udder health drug cost, and the quantity
of marketed milk in a year. When calculating the
annual fertility treatment drug cost, the given year's
amount of drugs used to treat reproductive disorders
has to be divided by the total number of progeny
(calves) [3].
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Table 1. Udder health and fertility treatment drug costs
In the case of the specific udder health drug costs
(Table 1.), we can see a 18.5% decrease in 2013,
which was caused by a more than one million litres
increase in milk production. However, the udder
health drug costs per litre increased by 7.6% in 2014.
This was caused by the increase in costs of udder
treatments, while the milk produced that year was
barely more than in the previous year. Compared to
the average 0.72 HUF/l on this farm, the previous
Hungarian surveys showed 0.6 l HUF/l/year [6] and
0.5 HUF/l/year [8] udder health drug cost/litre milk.
These are 15-20% lower than our results. This
difference might be because the dairy herd has lower
than average lactatitional milk production. We can see
how the status of udder health in the herd is unstable,
since after the remarkable improvement in the middle
year, it slightly deteriorated again in 2014. During the
entire three year long period of the survey the milk
production increased by nearly 25%, but the total
drug cost barely increased by 10%, thus the specific
udder health drug costs decreased by 12.3%.
The annual fertility treatment drug costs (Figure 1.)
showed near identical data in the first two years -
3,664 HUF and 3,068 HUF per liveborn calf.
However, in the third year, this index decreased by
nearly 30% - to 2,583 HUF per calf, which was was
caused by the 30% increase in the number of liveborn
calves. The latter value is also a bit higher than the
value calculated by Ózsvári et al. (2003) - 2,364
HUF/calf/year. The efficiency of drug usage to treat
and prevent reproductive disorders in the surveyed
three years is hard to evaluate. The company sold in-
calf heifers to the east multiple times, and purchased
calves and in-calf heifers from the Netherlands. The
evaluation of data was scrambled due to the calving
of these animals that did not happen, or happened in
excess. Anyway, the analyses say that if the herd
fertility status deteriorates, the fertility treatment drug
usage increases. If we also take the previously shown
production data into consideration as well, we can see
that due to the high number of pregnant heifers that
calved, further increase in milk production is
expected.
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Figure 1. Trends in the annual fertility treatment and udder health drug costs
4.1.2. Correlations between drug costs and
mortality rates
We also calculated the drug cost per calf, which is the
quotient of the yearly costs of antibiotics used to treat
calves and the annual progeny (Table 2.). After this,
we evaluated the correlation between calf mortality
rate and calf health management drug costs. We also
calculated the costs of drugs used to prevent and treat
diseases of calves until they became 6 months old,
which was an average of 2,286 HUF. 
Table 2. Annual total drug cost per calf/cow and mortality rates
The calf mortality rate increased by more than
116% in the second year of the analysis. The drastic
increase (more than 520%) in the antibiotics cost
cannot be verified by the mortality rate. The amount
spent for antibiotics didn't increase significantly in
2014, but the mortality rate further deteriorated by
21.3%. Based on the evaluation, we can say that the
calf raising technology, and its preventative and
treatment protocol have to be changed on this dairy
farm. The annual total drug cost per cow on this dairy
farm reached an average of 23,582 HUF. The
analyses of Ózsvári et al. (2003) measured much less
– 8,000 to 12,000 HUF on average – whereas Szerémi
(2007) measured 17,716 HUF. Varga and Ózsvári
(2004) also found a 31,500 annual total drug cost per
cow in their analysis. The dairy farm showed a nearly
identical value – 22,984 HUF and 22,928 HUF for
2012 and 2014 respectively – in our analysis.
However, for the year 2013, the costs increased by
more than 8% - up to 24,834 HUF. The average
mortality rate for the three years was 3.4%, which is
below the 5.2% value Ózsvári et al. (2003) calculated
in their former analysis.
4.1.3. Return on drug costs
We calculated the return on drug costs in order to
evaluate the financial efficiency of herd health
management on the farm. As part of this, we
calculated how much extra milk results from the total
udder health drug costs, how many extra calves result
from the total fertility treatment costs, and finally,
how many litres of extra milk per cow is worth as
much as the total drug cost per cow annually. The
calculations required the average buy-up prices of
raw milk in the given years. In the case of the dairy
farm, this price was 89.6 HUF for 2012, 101.6 HUF
for 2013, and 106.3 HUF for 2014. The market price
of a suckling calf for the first two years was set to
45,000 HUF. In the third year, calves couldn't be sold
in their first two weeks of their life, due to bluetongue
outbreaks in Hungary. This resulted in a higher calf
market value of 50,000 HUF which was used in the
calculation for the year 2014. It is because of that the
average market price of calves sold finally at the end
of 2014 was higher, but their liveweight price per
kilogram didn't even reach half of the previous
suckling calf price, as those were sold when they were
8-15 weeks old. The data is summarized in Table 3.
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Table 3. Return on drug costs
Figure 2. Return on total drug costs
The costs of udder health drugs generate a return in
case of an excess milk of 42.9 l for each cow, which
is much less than the amount either Ózsvári et al.
(54.9-96.8) [6] or Szerémi (63.28) [8] calculated in
their studies. One of the main reasons for this is that
when we conducted our research, the price of milk
was more than 50% higher. The buy-up price of raw
milk constantly increased during the three years of
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our analysis, while the costs of udder health drugs
increased by 5% in the second year, but decreased by
8% in the third year. Based on all this, we can
understand how the costs of drugs generated a return
with much less extra milk. The higher costs of 2013
were compensated by the higher buy-up price of milk.
The fertility treatment drug costs generate a return, if
there's an annual 0.07 extra calf born per cow. This
kind of cost decreased by 23.5% in the surveyed time
period. As the market prices of calves only increased
by 11%, we can explain how the number of extra
calves required to recover the drug costs decreased
from 0.07 to 0.05 calf/cow/year. The costs spent for
fertility treatments in Ózsvári et al. [6] generated a
return more easily, with 0.04 extra calves. However,
Szerémi's [8] return was much higher, 0.12. The
annual drug costs per cow for the three years
generates a return for 237.8 litres of extra milk per
cow. The drug costs per cow for 2013 were 8% higher
compared to those of 2012 or 2014. The annual
market price of milk increased each year, which
caused the return to be generated even with nearly
16% less extra milk (Figure 2). The 349.7 l
milk/cow/year annual figure calculated by Varga and
Ózsvári [7] is substantially higher than that we
calculated. However, Szerémi's [8] result of 279.4 l
is much closer to the data we calculated in this
analysis.
5. Conclusions
Summarily, we can conclude that apart from calf
health management, the herd health management on
the farm is adequate, and the drug costs are recovered
quickly (though admittedly, the high milk prices also
helped in the surveyed period). The goals of the dairy
farm's management is to achieve the calf health
management indices of 2012, the milk production
parameters of 2013, and the number of cows and
calvings of 2014 from 2015. The tight cooperation of
experts on feeding, animal hygiene, milking,
reproduction and herd health management is needed
for completing these goals. 
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